555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [xổ số đài]
DAPA-CKD: Trial design Conducted 2 Feb. 2017 to 12 June 2020*; 21 countries, 386 sites, 4304 participants; median follow-up 2.4 years.
Abstract Commentary on: Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020;383:1436-46. Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George's, University of London, UK.
Sep 24, 2020 · Heerspink HJL, Stefansson BV, Chertow GM, et al. Rationale and protocol of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled...
Main results. On March 26, 2020, the independent data monitoring committee recommended stopping the trial because of clear efficacy on the basis of 408 primary outcome events. The participants were 61.8 ± 12.1 years of age, and 1425 participants (33.1%) were female.
Nov 13, 2020 · Secondary prevention patients (n=1610; 37.4%) were older, were more often male, had a higher blood pressure and body mass index, and were more likely to have diabetes.
Oct 8, 2020 · Dapagliflozin in Patients with Chronic Kidney Disease October 2020 The New-England Medical Review and Journal 8 (383 (15)):1436-1446 Authors: Naufal Zagidullin Bashkir State Medical...
Abstract Heerspink HJ, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436-46. 32970396.
Oct 8, 2020 · Dapagliflozin in Patients with Chronic Kidney Disease N Engl J Med. 2020 Oct 8;383 (15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
Aug 28, 2020 · Presented by Dr. Hiddo J.L. Heerspink at the European Society of Cardiology Virtual Congress, August 30, 2020. Rationale and protocol: Heerspink HJ, Stefansson BV, Chertow GM, et al., on behalf of the DAPA-CKD Investigators.
Sep 24, 2020 · Heerspink HJL, Stefansson BV, Cher-tow GM, et al. Rationale and protocol of the Dapagliflozin and Prevention of Ad-verse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled...
Bài viết được đề xuất: